Related Experiment Video
Updated: Jun 14, 2025

12:00
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
15.5K
A Novel Bioabsorbable Covered Stent for Advancing Bile Duct Injury Management: A Preclinical Study in a Porcine Model
Mitsuo Miyazawa1, Masayasu Aikawa2, Junpei Takashima3
1Center for Preventive Medicine International University of Health and Welfare Narita Hospital Narita Japan.
DEN Open
|June 12, 2025
Summary
A novel self-expandable bioabsorbable covered stent (SEBCS) shows promise for treating bile duct injuries. This innovative stent facilitated bile duct regeneration and prevented stenosis in a preclinical study.
Area of Science:
- Gastroenterology and Hepatology
- Biomaterials Science
- Surgical Innovation
Background:
- Biliary tract injuries pose significant clinical challenges.
- Current treatments using metallic and plastic stents have limitations.
- Novel therapeutic approaches are needed for effective bile duct injury management.
Purpose of the Study:
- To evaluate the efficacy of a novel self-expandable bioabsorbable covered stent (SEBCS) for treating bile duct injuries.
- To assess the regenerative potential of SEBCS in extrahepatic bile duct injury models.
- To determine the safety and feasibility of SEBCS implantation.
Main Methods:
- Development of a novel SEBCS by covering a self-expandable bioabsorbable stent with a bioabsorbable tube.
- Surgical implantation of SEBCS into the extrahepatic bile ducts of five pigs under general anesthesia.
- Postoperative monitoring including hepatobiliary enzyme levels, histological evaluation, and cholangiography at 10 weeks.
Main Results:
- Successful SEBCS insertion into all animal subjects.
- Histological analysis revealed significant epithelial regeneration and peribiliary gland formation at the injury site.
- Cholangiography confirmed the absence of stenosis in the injured bile ducts.
- Hepatobiliary enzyme levels showed transient mild elevation, returning to baseline by 10 weeks.
Conclusions:
- The novel SEBCS demonstrated potential for promoting bile duct regeneration.
- SEBCS implantation appears to be a safe and feasible endoscopic treatment for extrahepatic bile duct injuries.
- This technology holds promise as an innovative therapeutic option for biliary tract injuries.

